Latest News

Holding(s) in Company

Notification of major interests in shares

Physiomics wins new deal with global pharma

Oxford-based biology company Physiomics has signed a new contract with a global pharmaceutical company. The project...

New deal with global pharma

Miscellaneous medium priority announcements

Physiomics raises up to £562,500

Physiomics has raised up to 562,500 through the issue of new equity at 0.18p per new ordinary share and the execution of a...

All News

29-08-14Holding(s) in CompanyRNS
14-08-14Physiomics wins new deal with global pharmaStockMarketWire
14-08-14New deal with global pharmaRNS
24-07-14Physiomics raises up to £562,500StockMarketWire
24-07-14Issue of EquityRNS
26-06-14Holding(s) in CompanyRNS
12-06-14Physiomics in anticipated new collaboration with DiatechStockMarketWire
12-06-14Anticipated new collaboration with DiatechRNS
20-05-14Holding(s) in CompanyRNS
10-04-14Second validation of Virtual Tumour ClinicalRNS
03-04-14Virtual Tumour Clinical ValidationRNS
14-02-14Physiomics narrows H1 pretax loss to £0.21mStockMarketWire
14-02-14Half Yearly ReportRNS
30-01-14Issue of Equity - ReplacementRNS
30-01-14Physiomics issues shares under SEDAStockMarketWire
30-01-14Issue of EquityRNS
16-01-14Physiomics to work with Dundee UniversityStockMarketWire
16-01-14Dundee University CollaborationRNS
17-12-13Physiomics resolutions passed at AGMStockMarketWire
17-12-13Result of AGMRNS
04-12-13Physiomics wins pharmaceutical contractStockMarketWire
04-12-13Virtual Tumour ProposalRNS
28-11-13Physiomics launches DrugCARD databaseStockMarketWire
28-11-13DrugCARD launchRNS
15-11-13Physiomics narrows FY pretax loss to £0.54mStockMarketWire
15-11-13Final ResultsRNS
11-11-13Physiomics in virtual tumour research collaborationStockMarketWire
11-11-13University of Oxford CollaborationRNS
04-11-13Update on the Virtual Tumour Clinical platformRNS
10-10-13Trends and Targets for 11/10/2013Trends and Targets
10-10-13Upcoming info.Trends and Targets
10-10-13Physiomics draws down £240,000StockMarketWire
10-10-13Drawdown pursuant to SEDA Arrngmnt/Issue of EquityRNS
07-10-13Physiomics gains new speciality pharma customerRNS
01-10-13Physiomics sign up large new customerStockMarketWire
01-10-13Physiomics gains first large pharma customerRNS
16-09-13Physiomics to present cardiac toxicity platformRNS
26-07-13Physiomics in equity issueStockMarketWire
26-07-13Issue of EquityRNS
01-07-13Additional SEDA DrawdownRNS

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory